דונפזיל טבע   10 מג ישראל - עברית - Ministry of Health

דונפזיל טבע 10 מג

teva pharmaceutical industries ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg - donepezil

ממוריט 10 ישראל - עברית - Ministry of Health

ממוריט 10

unipharm ltd, israel - donepezil hydrochloride - טבליה - donepezil hydrochloride 10 mg

אנראביק % 10 וטרינרי ישראל - עברית - Ministry of Health

אנראביק % 10 וטרינרי

abic veterinary products ltd - enrofloxacin - תמיסה - enrofloxacin 100 mg/ml

אומפרדקס קפליות 10 מג ישראל - עברית - Ministry of Health

אומפרדקס קפליות 10 מג

dexcel ltd, israel - omeprazole - קפליות - omeprazole 10 mg - omeprazole - omeprazole - acute duodenal ulcer. acute gastric ulcer. reflux esophagitis: treatment , long - term management. maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. maintenance treatment for the prevention of relapse in patients with poorly reponsive peptic ulcer. zollinger-ellison syndrome. treatment and prevention of nsaid-associated duodenal and gastric ulcers or erosions in high risk patients. treatment of severe reflux oesophagitis in children overthe age of 6 year. helicobacter pylori - associated peptic ulcer disease in combination with antibiotics.

קומדין 10 מג ישראל - עברית - Ministry of Health

קומדין 10 מג

taro pharmaceutical industries ltd - warfarin sodium - טבליה - warfarin sodium 10 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.

קסרלטו 10 מג ישראל - עברית - Ministry of Health

קסרלטו 10 מג

bayer israel ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 10 mg - rivaroxaban - rivaroxaban - prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.

קסרלטו 10 מג ישראל - עברית - Ministry of Health

קסרלטו 10 מג

bayer israel ltd - rivaroxaban - טבליות מצופות פילם - rivaroxaban 10 mg - rivaroxaban - rivaroxaban - prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.

חומצה פולית 10 מג ישראל - עברית - Ministry of Health

חומצה פולית 10 מג

rekah pharmaceutical industry ltd, israel - folic acid - טבליה - folic acid 10 mg - folic acid - folic acid - treatment of folic acid deficiency megaloblastic anemia in malabsorption states.

גלוקוז % 10 ישראל - עברית - Ministry of Health

גלוקוז % 10

lapidot medical import and marketing ltd - glucose as monohydrate - תמיסה לאינפוזיה - glucose as monohydrate 10 % - glucose - glucose - carbohydrate infusion therapy : hypoglycaemic situations, hypertonic dehydration , hypertonic electrolyte disturbances. vehicle solution for supplementary medication.

פרימן % 10 ישראל - עברית - Ministry of Health

פרימן % 10

remedix care ltd - glycine; l- alanine; l- aspartic acid; l- cysteine; l- glutamic acid; l- isoleucine; l- leucine; l- lysine; l- methionine; l- ornithine hydrochloride; l- phenylalanine; l- proline; l- serine; l- threonine; l- tryptophan; l- tyrosine; l- valine; l-arginine; l-histidine; taurine - תמיסה לאינפוזיה - l- valine 0.76 g / 100 ml; l- tyrosine 0.045 g / 100 ml; l- tryptophan 0.2 g / 100 ml; l- threonine 0.37 g / 100 ml; taurine 0.06 g / 100 ml; l- serine 0.4 g / 100 ml; l- proline 0.3 g / 100 ml; l- phenylalanine 0.42 g / 100 ml; l- ornithine hydrochloride 0.318 g / 100 ml; l- methionine 0.24 g / 100 ml; l- lysine 1.1 g / 100 ml; l- leucine 1.0 g / 100 ml; l- isoleucine 0.67 g / 100 ml; l-histidine 0.38 g / 100 ml; glycine 0.4 g / 100 ml; l- glutamic acid 1.0 g / 100 ml; l- cysteine 0.189 g / 100 ml; l- aspartic acid 0.6 g / 100 ml; l-arginine 0.84 g / 100 ml; l- alanine 0.8 g / 100 ml - lysine - lysine - primene 10 % is indicated in 1) children and infants 2) neonates at term or premature of normal or low birth weight when oral or enteral nutrition is impossible insufficient or contraindicated.